© 2021 MJH Life Sciences™ and Oncology Nursing News. All rights reserved.
Laura Wood on Multidisciplinary Collaboration for Managing Immunotherapy Adverse Events
January 13, 2017
Laura Wood, RN, MSN, OCN
Laura Wood, RN, MSN, OCN
Laura Wood on collaboration between departments when treating patients with cancer who are receiving immunotherapy treatments.
Laura Wood, RN, MSN, OCN, Cleveland Clinic explains the importance of a multidisciplinary approach when treating patients on immunotherapy.
Patients receiving immunotherapy treatments have autoimmune-type adverse events that are unlike those of chemotherapy. The side effects can be prolonged and require careful monitoring as well as multidisciplinary collaboration. Checking in with gastrointestinal, endocrinology, and other specialists can help to manage and monitor these side effects.
Related Content: